Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2906456 | 0.90 | LMNA (0.51) | TSHRTDP1L3MBTL1ALDH1A1TP53 | |
| SCHEMBL365814 | 0.84 | TDP1 (0.53) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL2900868 | 0.83 | MEN1 (0.56) | TSHRL3MBTL1ALDH1A1MAPK1KDM4E | |
| SCHEMBL7005225 | 0.77 | TSHR (0.47) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL9595722 | 0.77 | TDP1 (0.55) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL7945226 | 0.77 | TDP1 (0.49) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL6622376 | 0.77 | MEN1 (0.50) | TDP1L3MBTL1KDM4ELMNARECQL | |
| SCHEMBL5675140 | 0.77 | TSHR (0.54) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| Phenol SCHEMBL2362180 | 0.76 | TSHR (0.59) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL15673155 | 0.75 | KMT2A (0.70) | TSHRTDP1L3MBTL1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8994016-B2 | Dielectric layer for an electronic device | XEROX CORPORATION (US) | 2015-03-31 | — | — | US | disclosed |
| US-20130331512-A1 | DIELECTRIC LAYER FOR AN ELECTRONIC DEVICE | XEROX CORPORATION (US) | 2013-12-12 | — | — | US | disclosed |
| US-8513650-B2 | Dielectric layer for an electronic device | XEROX CORPORATION (US) | 2013-08-20 | — | — | US | disclosed |
| US-8425808-B2 | Semiconducting composition | XEROX CORPORATION (US) | 2013-04-23 | — | — | US | disclosed |
| US-20110260114-A1 | SEMICONDUCTING COMPOSITION | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20100301344-A1 | DIELECTRIC LAYER FOR AN ELECTRONIC DEVICE | XEROX CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| EP-2256797-A2 | Dielectric layer for an electronic device | Xerox Corporation (US) | 2010-12-01 | — | — | EP | disclosed |
| EP-2217564-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XenoPort, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2009033054-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | ADSL, SLC19A1, SLC25A21 | TSHR 2112/4885TDP1 2099/4885L3MBTL1 4678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.